Industry | 2017.08.08
NVLS: Emerging Technology Means Shift Needed Towards Diagnostic Testing Markets
Cancer diagnostics technology continues to evolve, with emerging science based in precision medicine beginning to dominate the industry. Even though global markets are primarily focused on cancer therapeutics, new trends in the development of cancer diagnostic technology will shape the future of these markets.
(PRWeb August 08, 2017)
Read the full story at http://www.prweb.com/releases/2017/08/prweb14580556.htm
For more information, please visit
http://www.prweb.com/releases/2017/08/prweb14580556.htm
